Dr. Rahmuddin khan | Pharmaceutics Awards | Best Researcher Award

Posted on by ScienceFather

Dr. Rahmuddin khan | Pharmaceutics Awards | Best Researcher Award

Dr. Rahmuddin khan, jamia hamdard, India

Dr. Rahmuddin is a skilled pharmaceutics researcher specializing in nano-based drug delivery systems for topical diseases, with a primary focus on psoriasis. Currently affiliated with the Nanomedicine Lab at Jamia Hamdard, New Delhi, he has a rich background in developing functional excipients and enhancing drug solubility through novel formulations. His academic path, from a Bachelor’s to a Ph.D. in Pharmaceutics at Jamia Hamdard, has cultivated his expertise across several scientific domains. Rahmuddin’s research includes hands-on experience with regulatory safety, non-clinical assessments, and industry-sponsored projects involving fulvic acid-based nanoformulations. Known for his analytical thinking, scientific writing, and mentorship, he has published extensively in reputable journals, showcasing advancements in nanoemulsion gels for conditions like psoriasis and tuberculosis. His collaborative work with New Zealand Fulvic Acid Limited and Reckitt Benckiser demonstrates his commitment to bridging industry with academic research for innovative therapeutic solutions.

Professional Profile:

Google Scholar

Suitability for the Best Researcher Award:

Dr. Rahmuddin is a highly deserving candidate for the Best Researcher Award due to his significant contributions to the field of pharmaceutics, particularly in the area of nano-based drug delivery systems for topical diseases such as psoriasis. His innovative research focuses on enhancing drug solubility and improving the effectiveness of topical treatments through novel formulations, including nanoemulsion gels. Dr. Rahmuddin’s academic background, culminating in his Ph.D. from Jamia Hamdard, showcases his deep understanding of pharmaceutics and his dedication to advancing drug delivery systems. His work with industry collaborators like New Zealand Fulvic Acid Limited and Reckitt Benckiser demonstrates his ability to bridge the gap between academia and industry, driving practical solutions for complex medical challenges.

🎓Education :

Rahmuddin completed his entire academic journey in Pharmaceutics at Jamia Hamdard, New Delhi, earning his Ph.D. in 2023. His doctoral thesis, titled “Novel Functional Excipient Appended System for Psoriasis,” explored advanced nano-based drug delivery systems, aimed at enhancing topical treatments. Prior to his Ph.D., he completed his M.Pharm in 2018, where he focused on “Exploration of Novel Peat-Sourced Fulvic Acid for Solubility Improvement of BCS Class II Drugs.” This research tackled the challenge of drug solubility by investigating natural compounds with pharmaceutical potential. He began his academic career with a B.Pharm in 2016 from the same institution, laying a solid foundation in pharmacy, pharmaceutics, and research methodologies. Throughout his academic journey, he developed strong technical expertise in drug formulation, excipient selection, and nano-delivery systems, equipping him with the necessary skills to innovate within the field of targeted drug delivery.

🏢Experience :

Rahmuddin’s professional experience spans academia, industry collaboration, and regulatory roles. His most recent role as a Consumer Safety Assistant at Reckitt Benckiser (May–Oct 2024) involved ensuring regulatory compliance and conducting non-clinical safety assessments. During his M.Pharm, he worked as a Research Associate on an industry-sponsored project with New Zealand Fulvic Acid Limited, focused on fulvic acid-based nanoformulations, an experience that honed his skills in drug delivery for pharmaceutical applications. His extensive research as a Ph.D. candidate at Jamia Hamdard (Dec 2018–Nov 2023) allowed him to specialize in topical drug delivery systems and provided opportunities to mentor M.Pharm and Ph.D. students. He has gained substantial laboratory experience, working with equipment like UV spectrophotometers, HPLC, tablet compression machines, and dissolution apparatuses, making him proficient in both theoretical knowledge and practical skills essential for pharmaceutical research.

🏅Awards and Honors :

Rahmuddin has received recognition for his work through various academic and industry-sponsored projects. Notably, his collaboration with New Zealand Fulvic Acid Limited on a project involving fulvic acid-based nanoformulations earned him significant acclaim, highlighting his contributions to innovative drug delivery research. His dedication to advancing drug solubility and effectiveness has been acknowledged within the academic community, where he has been a mentor and guide for students exploring solutions for complex diseases like psoriasis and tuberculosis. His publications in reputable journals, featuring targeted treatments and polysaccharide-based nano-drug delivery vehicles, showcase his commitment to expanding the applications of nano-based therapies. Through his professional experience and academic guidance, Rahmuddin continues to impact the field of pharmaceutics, bridging industry needs with academic insights to support advancements in the treatment of chronic diseases.

🔬Research Focus :

Rahmuddin’s research centers on the development of nano-based drug delivery systems for topical treatments, especially focusing on diseases like psoriasis. His work includes the creation of innovative excipients and nanoemulsion gels that improve drug solubility and targeted delivery, addressing issues faced with conventional formulations. In collaboration with New Zealand Fulvic Acid Limited, he has explored the pharmaceutical potential of fulvic acid for enhancing drug solubility, contributing to advancements in drug delivery systems. His technical skills encompass various analytical tools, including HPLC, UV spectrophotometry, and tablet compression machines, allowing him to design and assess complex formulations. Rahmuddin’s research portfolio spans a broad range of disease models beyond psoriasis, including acne and tuberculosis, exemplifying his commitment to leveraging nanotechnology for enhanced therapeutic outcomes. His contributions to scientific literature and mentorship to upcoming researchers further solidify his role as an innovative force in pharmaceutics.

Publication Top Notes:

  • “In vitro and in vivo investigation of a dual-targeted nanoemulsion gel for the amelioration of psoriasis”
    • Citations: 24
  • “A pharmaco-technical investigation of thymoquinone and peat-sourced fulvic acid nanoemulgel: a combination therapy”
    • Citations: 16
  • “Pharmacokinetic evaluation of fulvic acid-ketoconazole complexes: A validation and line extension study”
    • Citations: 7
  • “Neuroprotective effects of trigonelline in kainic acid-induced epilepsy: Behavioral, biochemical, and functional insights”
    • Citations: 5
  • “COVID-19 pandemic challenges and their management: A review of medicines, vaccines, patents and clinical trials with emphasis on psychological health issues”
    • Citations: 4

 

 

 

Prof. Dr. Meltem Muftuoglu | Drug delivery Awards | Best Researcher Award

Posted on by ScienceFather

Prof. Dr. Meltem Muftuoglu | Drug delivery Awards | Best Researcher Award

Prof. Dr. Meltem Muftuoglu, Acibadem Mehmet Ali Aydinlar University, Turkey

Professor Meltem Muftuoglu is a distinguished molecular biologist and biochemist based at Acibadem Mehmet Ali Aydinlar University in Istanbul, Turkey. She holds dual professorships in the Departments of Molecular Biology and Genetics and Medical Biotechnology. Prof. Muftuoglu earned her Ph.D. in Biochemistry from Hacettepe University and has extensive research experience in molecular genetics and cellular medicine, including postdoctoral work at the NIH’s National Institute on Aging. Her work focuses on cancer drug delivery, mitochondrial targeting therapies, and DNA repair mechanisms, with numerous peer-reviewed publications in high-impact journals. An NIH and NATO A2 Scholar, she has received various awards, reflecting her significant contributions to biochemistry and molecular biology.

Professional Profile:

Scopus

Orcid

Suitability for the Best Researcher Award: Professor Meltem Muftuoglu

Summary of Suitability:

Professor Meltem Muftuoglu’s extensive academic and research career makes her an exemplary candidate for the Best Researcher Award. Her tenure at leading institutions, including her current professorship at Acibadem Mehmet Ali Aydinlar University in Istanbul, Turkey, underscores her commitment to advancing knowledge in molecular biology and medical biotechnology.

🎓Education:

Professor Meltem Muftuoglu holds a comprehensive academic background in biochemistry and biological sciences. She earned her B.Sc. in Biological Sciences in 1991 from Middle East Technical University in Ankara, Turkey. She then pursued graduate studies at Hacettepe University, Faculty of Medicine, where she completed an M.Sc. in Biochemistry in 1995 and subsequently a Ph.D. in Biochemistry in 2001. Recognized for her expertise, she received a docent degree in Biochemistry from the Higher Education Council in Ankara in 2005. Since 2015, Professor Muftuoglu has served as a Professor at Acibadem Mehmet Ali Aydinlar University in Istanbul, Turkey, where she contributes significantly to the fields of molecular biology and biotechnology.

🏢Work Experience:

Professor Meltem Muftuoglu has an extensive career in academia and research, marked by key positions across leading institutions worldwide. Since 2015, she has held a professorship at the Department of Molecular Biology and Genetics at Acibadem Mehmet Ali Aydinlar University in Istanbul, Turkey, and since 2018, she has also been a professor in the university’s Department of Medical Biotechnology. Prior to these roles, she served as an Associate Professor at the same university in Molecular Biology and Genetics (2014–2015) and at Koc University’s School of Medicine in the Department of Biochemistry (2011–2014). From 2009 to 2011, she was an Assistant Professor at the University of Copenhagen’s Department of Cellular and Molecular Medicine. Her research journey also includes a prestigious postdoctoral fellowship at the Laboratory of Molecular Gerontology, National Institute on Aging (NIH), in the United States (2004–2009). Additionally, she has served as an Assistant Professor in the Department of Biochemistry at Hacettepe University in Ankara, Turkey (2001–2004), and as a Research Scholar in the Laboratory of Molecular Genetics at the NIH’s National Institute on Aging (1999–2000). Earlier in her career, she was a Teaching and Research Assistant in Biochemistry at Hacettepe University (1993–2001), establishing a strong foundation for her distinguished work in biochemistry and molecular biology.

🏅Awards and Scholarships:

Throughout her career, Professor Meltem Muftuoglu has been recognized with numerous prestigious awards that highlight her contributions and commitment to scientific research. From 2004 to 2009, she was honored with the NIH Ruth L. Kirschstein National Research Service Award (NRSA), underscoring her excellence in research at the National Institute on Aging. In 2005, she was celebrated at the International Academy of Achievement Summit, reflecting her notable achievements in the field. Earlier, she was awarded the NATO A2 Scholarship by the Scientific and Technical Research Council of Turkey in 1998, and during 1999–2000, she received the NIH Fogarty Scholarship, further affirming her dedication to advancing biochemistry and molecular biology on a global scale.

🔬Research Focus:

Professor Muftuoglu’s research centers on advancing cancer therapeutics, mitochondrial targeting, and understanding DNA repair mechanisms. Her work in cancer drug delivery focuses on developing novel methods, including hydrophobin-coated and mitochondria-targeted liposomes, for more efficient and precise drug delivery to cancer cells. She is also exploring mitochondrial targeting therapies, which seek to selectively deliver drugs to mitochondria, enhancing both the efficacy and specificity of cancer treatments. Additionally, Professor Muftuoglu investigates DNA repair mechanisms, particularly base excision repair pathways, to uncover genetic factors that impact diseases like Alzheimer’s and various cancers.

Publication Top Notes:

  • Cosmic Whirl: Navigating the Comet Trail in DNA: H2AX Phosphorylation and the Enigma of Uncertain Significance Variants
  • Formulation Development and Evaluation of Fluvastatin Loaded Transethosomes: Characterization, Stability, In Vitro Dermal Penetration, Cytotoxicity and Antipsoriatic Activity Studies
    • Citations: 1
  • Targeting Mitochondrial DNA Polymerase Gamma for Selective Inhibition of MLH1 Deficient Colon Cancer Growth
    • Citations: 8
  • Leukocyte Telomere Length as a Compensatory Mechanism in Vitamin D Metabolism
    • Citations: 3
  • Parents of Ataxia-Telangiectasia Patients Display a Distinct Cellular Immune Phenotype Mimicking ATM-Mutated Patients
    • Citations: 5